Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 3/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 4/20 | 0.33 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.33 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 3/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL472066 | 0.90 | CYP3A4 (0.33) | CYP3A4TSHRNPSR1ALDH1A1HSD17B10 | |
| SCHEMBL3788158 | 0.87 | CYP3A4 (0.32) | CYP3A4TSHRTP53GAARECQL | |
| SCHEMBL7196359 | 0.86 | CYP3A4 (0.42) | CYP3A4TSHRALDH1A1HSD17B10TDP1 | |
| SCHEMBL7175708 | 0.79 | CYP3A4 (0.38) | CYP3A4TSHRNPSR1ALDH1A1HSD17B10 | |
| SCHEMBL472154 | 0.77 | ALDH1A1 (0.30) | CYP3A4TSHRALDH1A1HSD17B10TDP1 | |
| SCHEMBL20183945 | 0.77 | CYP3A4 (0.39) | CYP3A4TSHRNPSR1ALDH1A1HSD17B10 | |
| SCHEMBL29893241 | 0.77 | TSHR (0.34) | CYP3A4TSHRTDP1MAPTCACNA1B | |
| SCHEMBL28179914 | 0.77 | CYP3A4 (0.36) | CYP3A4TSHRALDH1A1HSD17B10TDP1 | |
| SCHEMBL7759124 | 0.76 | TSHR (0.38) | CYP3A4TSHRALDH1A1HSD17B10CA1 | |
| SCHEMBL2167134 | 0.76 | CYP3A4 (0.41) | CYP3A4TSHRNPSR1ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7696366-B2 | Production process of bifunctional epoxy monomer by selective oxidation of diolefin compound | SHOWA DENKO K.K. (JP) | 2010-04-13 | — | — | US | disclosed |
| EP-1891031-B1 | PRODUCTION PROCESS OF BIFUNCTIONAL EPOXY MONOMER BY SELECTIVE OXIDATION OF DIOLEFIN COMPOUND | SHOWA DENKO KK (JP) | 2009-03-11 | — | — | EP | disclosed |
| US-20090030217-A1 | PRODUCTION PROCESS OF BIFUNCTIONAL EPOXY MONOMER BY SELECTIVE OXIDATION OF DIOLEFIN COMPOUND | SHOWA DENKO K.K. (JP) | 2009-01-29 | — | — | US | disclosed |
| EP-1891031-A2 | PRODUCTION PROCESS OF BIFUNCTIONAL EPOXY MONOMER BY SELECTIVE OXIDATION OF DIOLEFIN COMPOUND | Showa Denko K.K. (JP) | 2008-02-27 | — | — | EP | disclosed |
| WO-2006123814-A2 | PRODUCTION PROCESS OF BIFUNCTIONAL EPOXY MONOMER BY SELECTIVE OXIDATION OF DIOLEFIN COMPOUND | SHOWA DENKO K.K. (JP) | 2006-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030217-A1 | PRODUCTION PROCESS OF BIFUNCTIONAL EPOXY MONOMER BY SELECTIVE OXIDATION OF DIOLEFIN COMPOUND | DUOX2, DUOX1, DDT | CYP3A4 798/4885TSHR 4623/4885NPSR1 3576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.